Medicare Enrolled
Dr. Dawn Kleinman, MD
Dermatology · Sanford, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kleinman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kleinman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kleinman
Dr. Dawn Kleinman is a dermatology specialist in Sanford, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kleinman performed 3,466 Medicare services across 1,904 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kleinman received a total of $43,552 from 43 pharmaceutical and/or device companies across 917 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kleinman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 37% volume in NC
$43,552 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,466
Medicare services
Top 37% in NC for dermatology
1,904
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~182 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,293 | $4 | $9 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
518 | $32 | $95 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
456 | $35 | $80 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
327 | $60 | $128 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
272 | $71 | $161 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
190 | $81 | $180 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
177 | $55 | $142 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
46 | $68 | $159 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
44 | $43 | $103 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $93 | $234 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
23 | $218 | $434 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
21 | $34 | $72 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
14 | $72 | $178 |
| Chemotherapy administration, 1-7 injections This procedure involves the administration of chemotherapy medication through one to seven separate injections. |
13 | $51 | $116 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
13 | $2 | $3 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
12 | $64 | $247 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
11 | $76 | $342 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$43,552
Total received (2018-2024)
Avg $6,222/year across 7 years
Top 7% in NC for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
917
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$23,372 (53.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,301 (37.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,879 (8.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,855
2023
$4,755
2022
$9,355
2021
$2,303
2020
$1,391
2019
$13,139
2018
$5,754
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$2,370
Incyte Corporation
$1,465
ABBVIE INC.
$897
Janssen Biotech, Inc.
$624
Regeneron Healthcare Solutions, Inc.
$301
E.R. Squibb & Sons, L.L.C.
$290
Dermavant Sciences, Inc.
$266
Amgen Inc.
$201
Arcutis Biotherapeutics, Inc.
$156
Lilly USA, LLC
$59
LEO Pharma Inc.
$56
GENZYME CORPORATION
$36
Janssen Scientific Affairs, LLC
$34
Novartis Pharmaceuticals Corporation
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Verrica Pharmaceuticals Inc.
$19
Biofrontera Inc.
$19
Galderma Laboratories, L.P.
$15
Top 3 companies account for 69.0% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$11,123
Janssen Scientific Affairs, LLC
$6,798
Incyte Corporation
$3,636
UCB, Inc.
$3,367
Janssen Biotech, Inc.
$2,585
AbbVie, Inc.
$2,541
ABBVIE INC.
$2,496
Amgen Inc.
$2,142
Regeneron Healthcare Solutions, Inc.
$1,252
Novartis Pharmaceuticals Corporation
$1,104
Lilly USA, LLC
$867
Sun Pharmaceutical Industries Inc.
$843
AbbVie Inc.
$606
PFIZER INC.
$514
GENZYME CORPORATION
$492
Dermavant Sciences, Inc.
$464
LEO Pharma Inc.
$400
Ortho Dermatologics, a division of Bausch Health US, LLC
$398
E.R. Squibb & Sons, L.L.C.
$390
Galderma Laboratories, L.P.
$376
Arcutis Biotherapeutics, Inc.
$223
Almirall LLC
$161
Mayne Pharma Inc.
$137
COMSORT, Inc
$100
Biofrontera Inc.
$73
Boehringer Ingelheim Pharmaceuticals, Inc.
$66
Verrica Pharmaceuticals Inc.
$43
EPI Health, LLC
$40
Aclaris Therapeutics, Inc.
$37
VYNE Pharmaceuticals Inc.
$35
Mission Pharmacal Company
$34
Paratek Pharmaceuticals, Inc.
$30
Sebela Pharmaceuticals Inc.
$21
PruGen, Inc. Pharmaceuticals
$19
Journey Medical Corporation
$18
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
Genentech USA, Inc.
$17
DUSA Pharmaceuticals, Inc.
$16
SANOFI-AVENTIS U.S. LLC
$16
DERMIRA, INC.
$16
Aegerion Pharmaceuticals, Inc.
$14
Bayer HealthCare Pharmaceuticals Inc.
$13
Helsinn Therapeutics (U.S.), Inc.
$11
Top 3 companies account for 49.5% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ADBRY · AKLIEF · AMELUZ · AMZEEQ · Absorica LD · Aczone · Ameluz · Avar · BLU-U · Bimzelx · CIBINQO · COSENTYX · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EFUDEX · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · FABRAZYME · Finacea · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · JUBLIA · JUXTAPID · Klisyri · LIBTAYO · NAFTIN · NUZYRA · ONEXTON · OPZELURA · ORACEA · Otezla · Ozanimod · PICATO · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VALCHLOR · VTAMA · WYNZORA · Winlevi · XOLAIR · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (54%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 7% for dermatology in NC.
Geographic Context
Dermatologists within 10 mi
21
Per 100K population
32.5
County median income
$63,060
Nearest hospital
CENTRAL CAROLINA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kleinman is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 7% of NC peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kleinman experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Kleinman performed 1,293 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kleinman receive payments from pharmaceutical companies?
Yes. Dr. Kleinman received a total of $43,552 from 43 companies across 917 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kleinman's costs compare to other dermatologists in Sanford?
Dr. Kleinman's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kleinman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Sanford
Browse dermatologists in Sanford ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in NC
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in NC
Which NC dermatologists receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology